Moderna Inc (NAS:MRNA)
$ 132.68 3.62 (2.8%) Market Cap: 50.83 Bil Enterprise Value: 42.17 Bil PE Ratio: 0 PB Ratio: 3.86 GF Score: 67/100

Q2 2021 Moderna Inc Earnings Call Transcript

Aug 05, 2021 / 12:00PM GMT
Release Date Price: $416.26 (-0.67%)
Operator

Good morning, and welcome to Moderna's Second Quarter Earnings Call. (Operator Instructions) Please be advised that the call is being recorded.

At this time, I would like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.

Lavina Talukdar
Moderna, Inc. - Senior VP & Head of IR

Thank you, operator. Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's Second Quarter 2021 Financial Results and Business Update. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website.

On today's call are Stéphane Bancel, our Chief Executive Officer; David Meline, our Chief Financial Officer; Stephen Hoge, our President; Paul Burton, our Chief Medical Officer; Corinne Le Goff, our Chief Commercial Officer; and Jackie Miller, our Senior Vice President, Therapeutic Head of Infectious Diseases.

Before we begin, please note that this conference call will include forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot